Skip to content

The assessment of the quality of movement control in patients with Parkinson*s disease receiving deep brain stimulation.

The assessment of the quality of movement control in patients with Parkinson*s disease receiving deep brain stimulation. - Assessing movement control in Parkinson*s disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30995
Enrollment
10
Registered
2007-10-02
Start date
2007-10-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

None listed

Sponsors

Medisch Spectrum Twente
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Parkinson patients having a deep brain stimulator in the subthalamic nucleus - Patients experiencing a good clinical result from DBS - Patients having no major fluctuations in symptoms due to medication - Patients being in good physical condition - Patients responding within 5 minutes to changes in the stimulator settings

Exclusion criteria

Exclusion criteria: - Patients not being able to fully cooperate with the experiments - Patients suffering from dementia - Patients suffering from severe dyskinesia

Design outcomes

Primary

MeasureTime frame
Parameters (obtained from the inertial sensors) relating to the UPDRS-scores for tremor, bradykinesia, and akinesia during three conditions are compared. These conditions are stimulator on with normal settings, stimulator on with altered settings, and stimulator off. The correlations of these parameters to the UPDRS-scores of tremor, bradykinesia, and akinesia is also assessed.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)